{"id":14219,"date":"2021-05-11T08:01:30","date_gmt":"2021-05-11T06:01:30","guid":{"rendered":"https:\/\/ggba.swiss\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/"},"modified":"2023-07-04T13:40:16","modified_gmt":"2023-07-04T11:40:16","slug":"vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/","title":{"rendered":"Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million"},"content":{"rendered":"<p>Headquartered at the <a href=\"https:\/\/epfl-innovationpark.ch\/\" target=\"_blank\" rel=\"noopener\">EPFL Innovation Park<\/a> in Lausanne, <a href=\"https:\/\/oculis.com\/\" target=\"_blank\" rel=\"noopener\">Oculis<\/a>\u00a0has a robust and expansive development portfolio including late-stage novel topical (eye drop) treatments, which are non-invasive and represent an unprecedented technical advance for patients with retinal edema and front-of-the-eye diseases.<\/p>\n<p>In addition, Oculis\u2019 formulation discovery and innovation capabilities enable the development of a pipeline of topical drugs targeting sight-threatening eye diseases that affect both the anterior and posterior segments of the eye.<\/p>\n<p>The Vaud-based company has closed a $57 million Series C financing round co-led by new investors\u00a0<a href=\"https:\/\/bvcf.com\/\" target=\"_blank\" rel=\"noopener\">BVCF Management<\/a>\u00a0and\u00a0<a href=\"http:\/\/www.hyfinityfund.com\/english.php\" target=\"_blank\" rel=\"noopener\">Hyfinity Investments<\/a>, with\u00a0<a href=\"https:\/\/www.vipartners.ch\/\" target=\"_blank\" rel=\"noopener\">VI Partners<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.willefinance.com\/\" target=\"_blank\" rel=\"noopener\">Wille AG<\/a>\u00a0joining the company\u2019s existing investors,\u00a0<a href=\"http:\/\/baycitycapital.com\/\" target=\"_blank\" rel=\"noopener\">Bay City Capital<\/a>,\u00a0<a href=\"https:\/\/www.brunnurventures.com\/\" target=\"_blank\" rel=\"noopener\">Brunnur Ventures<\/a> and\u00a0<a href=\"https:\/\/earlybird.com\/\" target=\"_blank\" rel=\"noopener\">EarlyBird<\/a>.<\/p>\n<p>Proceeds from this financing will accelerate Oculis\u2019 strategy. The targeted milestones cover the\u00a0development of novel topical therapies for ophthalmic diseases targeting the retina and anterior segment with high unmet needs.<\/p>\n<p>Zhi Yang, Managing Partner at BVCF Management, said: \u201cOculis\u2019 innovative science and transformative topical approach to address sight-threatening diseases have the potential to significantly extend the reach of such therapies to larger numbers of patients, improving accessibility and compliance and ultimately clinical outcomes. This unrivalled potential, the strength of the international team at Oculis, and growing unmet medical needs in major key markets around the world are the key factors behind the decision by BVCF and our fellow investors to participate in this new financing round.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A biopharmaceutical company focused on developing innovative ophthalmic treatments, Oculis has announced the closing of an oversubscribed $ 57 million Series C financing round.<\/p>\n","protected":false},"author":3,"featured_media":14220,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[912,894,902],"class_list":["post-14219","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-biotech","tag-financing","tag-personalized-medicine"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"A biopharmaceutical company focused on developing innovative ophthalmic treatments, Oculis has announced the closing of an oversubscribed $ 57 million Series C financing round.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-11T06:01:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:40:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"381\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million\",\"datePublished\":\"2021-05-11T06:01:30+00:00\",\"dateModified\":\"2023-07-04T11:40:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/\"},\"wordCount\":235,\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-4.jpg\",\"keywords\":[\"Biotech\",\"Financing\",\"Personalized Medicine\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/\",\"name\":\"Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-4.jpg\",\"datePublished\":\"2021-05-11T06:01:30+00:00\",\"dateModified\":\"2023-07-04T11:40:16+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-4.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-4.jpg\",\"width\":630,\"height\":381},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/","og_locale":"en_US","og_type":"article","og_title":"Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million - Greater Geneva Bern area","og_description":"A biopharmaceutical company focused on developing innovative ophthalmic treatments, Oculis has announced the closing of an oversubscribed $ 57 million Series C financing round.","og_url":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2021-05-11T06:01:30+00:00","article_modified_time":"2023-07-04T11:40:16+00:00","og_image":[{"width":630,"height":381,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-4.jpg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mathieu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#article","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million","datePublished":"2021-05-11T06:01:30+00:00","dateModified":"2023-07-04T11:40:16+00:00","mainEntityOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/"},"wordCount":235,"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-4.jpg","keywords":["Biotech","Financing","Personalized Medicine"],"articleSection":["Life sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/","url":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/","name":"Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#primaryimage"},"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-4.jpg","datePublished":"2021-05-11T06:01:30+00:00","dateModified":"2023-07-04T11:40:16+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-4.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Oculis-630x380-4.jpg","width":630,"height":381},{"@type":"BreadcrumbList","@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/en\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=14219"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14219\/revisions"}],"predecessor-version":[{"id":16930,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14219\/revisions\/16930"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/14220"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=14219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=14219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=14219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}